Snapshot from Jul 07, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Natco Pharma

Tracked across 4 events · 28 articles · First seen Mar 20, 2025 · Last active Jun 03, 2026

Sentiment
39
Attention
6
Events
4
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
6 80
Business
Impact: Natco Pharma is a key player in launching generic semaglutide in India at a significantly lower price, aiming to capture a substantial share of the weight-loss drug market.
Mar 20, 2026 · 8 articles
4 20
Business
Impact: Natco Pharma is one of several Indian companies that launched generic versions of semaglutide, increasing competition for Novo Nordisk.
Mar 30, 2026 · 8 articles
6 5
Business
Impact: Natco Pharma is one of the Indian generic drugmakers that will likely offer lower-priced versions of semaglutide once the patent expires.
Nov 11, 2025 · 6 articles
2 50
Business
Impact: Natco Pharma continues to be an investor in Pee Safe.
Mar 17, 2026 · 6 articles
India Natco Pharma
India Natco Pharma
ERGEN INTELLIGENCE
Track Natco Pharma live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.